🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This Expanded Access Program (EAP) is intended to provide daraxonrasib to e...
Status
Available
Location
Alabama Oncology
Start Date
TBD
Trial ID
NCT07573215
Treatments Being Tested
This study is a Phase 1 clinical trial testing an oral investigational drug...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-09
Trial ID
NCT07756281
Treatments Being Tested
The purpose of this study is to evaluate the safety, tolerability, pharmaco...
Status
Recruiting
Location
Yale Cancer Center
Start Date
2026-01-08
Trial ID
NCT07349537
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of a novel...
Status
Active Not Recruiting
Location
Banner MD Anderson Cancer Center
Start Date
2024-10-16
Trial ID
NCT06625320
The purpose of this study is to evaluate the safety and efficacy of a novel...
Status
Recruiting
Location
Alabama Oncology
Start Date
2025-05-06
Trial ID
NCT06881784
Treatments Being Tested
This study is to evaluate the safety, tolerability, and PK profiles of Elir...
Status
Recruiting
Location
City of Hope
Start Date
2023-11-14
Trial ID
NCT06128551
Treatments Being Tested
This is an open-label, multicenter Phase 2 study evaluating BMS-986504 in p...
Status
Recruiting
Location
Local Institution - 0096
Start Date
2026-07-27
Trial ID
NCT07492680
The purpose of this study is to evaluate the safety, tolerability, pharmaco...
Status
Recruiting
Location
USC Norris Comprehensive Cancer Center
Start Date
2026-01-30
Trial ID
NCT07397338
The purpose of this study is to evaluate the safety and efficacy of an inve...
Status
Recruiting
Location
Honor Health Research Institute
Start Date
2026-03-09
Trial ID
NCT07491445
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of a novel...
Status
Recruiting
Location
Mayo Clinic
Start Date
2025-12-15
Trial ID
NCT07252232
Treatments Being Tested